Seàn Ò Cearmada 🇮🇪

Private Investor , Value Investing Philosophy. Managing Concentrated Portfolio For Family + Friend’s. (Not investment advice)

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

$IVFH Innovation Food Holdings Potential multi-bagger 💎

▫️High-growth,
▫️Asset-light business,
▫️Priced at just 7X normalized EBITDA.
▫️With solid organic growth and a management team owning >40% of the company.

https://t.co/tmKViF9gxD

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

@FabrizioRomano BbbvxfjjgmgD

[Simon Handrahan | MOS Capital @MoS_Investing]

Boring is beautiful

[InsideArbitrage @InsideArbitrage]

Colorado-based cinema advertising network - $NCMI National CineMedia (+18% after hrs) Announces $100 Million Share Buyback through April 2027 Amidst Mixed Q4 Results & Market Challenges

$NCMI reported flat year-over-year revenue at $90.9 million for Q4 2023

The buyback represents around one-fourth of its current market cap!

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

@SebKrog Yea, nice bit of movement today for the first time in a while, I own a basket which could move 20% to 30% and still be cheap.
It’s all about owning what you think is cheap in comparison to intrinsic value.

[Iggy on Investing @IggyOnInvesting]

🔴 My full-length article on @dsmoak98, the small-cap investor boasting a 5-year 48% CAGR, is now live in my BIO!

🟠 The article covers all 16 incredible pitches shared by Daniel!

🟡 Many of these have turned into incredible multibaggers.

[Paul Andreola 🇨🇦 @PaulAndreola]

Here's an article we wrote in August of last year....

The Makings of a Ten-Bagger

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

@TrentBlair19 https://t.co/d0fyrEa8ow

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

$KLYG Kelyniam Global is an Illiquid Nano-Cap that could Multi-Bag in the coming years.
Let’s Dive in 👇🏻👇🏻👇🏻

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

$TMDX
▫️Exponential revenue growth, positive EPS in the last 2 Qtrs.

▫️The focus is not solely on revenue expansion, but also on turning profitable and generating free cash flow, indicating potential for sustainable success.

▫️Bit rich for me at 7.5X forward sales.

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

Well said Seth!!

[Brian Coughlin @EquityBrian]

Seth Klarman on modern day value investing

[Heisenberg @Mr_Derivatives]

$AAPL Still trading at same levels as Dec 2021

$GOOG Still trading at same levels as Aug 2021

$TSLA Still trading at same levels as Aug 2020

$AMZN Still trading at same levels as Aug 2020

Not nothing.

[Daniel Mahncke @MnkeDaniel]

One Up on Wall Street by Peter Lynch

One of the best books to read when you start investing:

[Daniel Mahncke @MnkeDaniel]

A One-Pager in Investing Lessons from Howard Marks:

[Dirtcheapstocks @dirtcheapstocks]

New Write up

The Butterfly Effect

A capital light, cash rich business with a hidden Saas segment. Despite incredible revenue growth and world class operating margins, shares trade for 5.5x EV/FCF.

Link in bio.

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

Still plenty of upside left here $EML.AX

$EML.AX announcement of selling its Sentenial business for $54M demonstrates the company's commitment to its strategic review. It's reassuring to see management following through on their promises, aligning with shareholder expectations.

[Jeremy Raper @puppyeh1]

$EML.AX 3mos on and stock is +50% and breaking new highs as Sentennial disposal announced, more or less in line w my expected valn and continuing record of strong execution against strategic plan from new management.

👌🏻👌🏻

[GURGAVIN @gurgavin]

PALANTIR CEO ALEX KARP ON SHORT SELLERS

“THEY (SHORT SELLERS) LOVE PULLING DOWN GREAT AMERICAN COMPANIES SO THEY CAN AFFORD THEIR COKE (COCAINE) . THE BEST OUTCOME FOR THEM WOULD BE IF WE LEAD THEIR COCAINE DEALERS TO THEIR HOMES AFTER THEY’RE UNABLE TO PAY THEIR BILLS.”

$PLTR

[power of books @Powerofbooks3]

Best biographies you must read in 2024

1. Einstein by Walter Isaacson

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

3. **Transformation Narrative:** Over the next twelve months, management's efforts to improve earnings quality, deleverage, and attract new customers are expected to reshape the investment narrative, potentially leading to significant upside for investors.

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

@CapitalVoss pitch for $RCM suggests a base case price of $21.05. Despite receiving a non-binding offer at $14, the stock is currently trading slightly above that level.

This could signal the possibility of a price increase or even a bidding war in the near future.

🧵👇🏻👇🏻

[Seàn Ò Cearmada 🇮🇪 @arbritrage86]

2. **Customer Growth:** With access to vast amounts of data and a strong customer base, R1 is well-positioned to attract new customers and drive revenue growth, particularly as hospitals seek more efficient revenue collection methods.